Root cause analysis of gastroduodenal ulceration after yttrium-90 radioembolization

CardioVascular and Interventional Radiology

Volumn 36, Issue 6, 2013, Pages 1536-1547

  Lam, Marnix G E H ^a,b   Banerjee, Subhas ^a   Louie, John D ^a   Abdelmaksoud, Mohamed H K ^a   Iagaru, Andrei H ^a   Ennen, Rebecca E ^a   Sze, Daniel Y ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Interventional Oncology; Liver Hepatic; Radioembolization Radioembolisation; ulcer

Indexed keywords

ANALGESIC AGENT; ANTIEMETIC AGENT; BEVACIZUMAB; FENTANYL; METHYLPREDNISOLONE; MICROSPHERE; PANTOPRAZOLE; SUCRALFATE;

ADULT; AGED; ANOREXIA; ARGON PLASMA COAGULATION; ARTICLE; ARTIFICIAL EMBOLISM; COIL EMBOLIZATION; DOSE CALCULATION; DYSPEPSIA; EPIGASTRIC PAIN; FEMALE; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN TISSUE; INJECTION PAIN; INTERVENTIONAL RADIOLOGY; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; MELENA; METASTASIS; NAUSEA; PEPTIC ULCER; PRIORITY JOURNAL; PYLORUS STENOSIS; RADIATION DOSE; RADIATION SAFETY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; ROOT CAUSE ANALYSIS; SATIETY; STOMACH HEMORRHAGE; VOMITING; YTTRIUM 90 RADIOEMBOLIZATION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; EMBOLIZATION, THERAPEUTIC; FEMALE; GASTROPARESIS; HUMANS; LIVER NEOPLASMS; MALE; MICROSPHERES; MIDDLE AGED; PEPTIC ULCER; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ROOT CAUSE ANALYSIS; YOUNG ADULT; YTTRIUM RADIOISOTOPES;

EID: 84888198128     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-013-0579-1     Document Type: Article

References (22)

1. Bilbao JI, de Martino A, de Luis E et al (2009) Biocompatibility, inflammatory response, and recannalization characteristics of nonradioactive resin microspheres: histological findings. Cardiovasc Intervent Radiol 32:727-736
2. Murthy R, Brown DB, Salem R et al (2007) Gastrointestinal complications associated with hepatic arterial yttrium-90 microsphere therapy. J Vasc Interv Radiol 18:553-561
3. Ogawa F, Mino-Kenudson M, Shimizu M et al (2008) Gastroduodenitis associated with yttrium 90-microsphere selective internal radiation: an iatrogenic complication in need of recognition. Arch Pathol Lab Med 132:1734-1738
4. Carretero C, Munoz-Navas M, Betes M et al (2007) Gastroduodenal injury after radioembolization of hepatic tumours. Am J Gastroenterol 102:1216-1220
5. Naymagon S, Warner RR, Patel K et al (2010) Gastroduodenal ulceration associated with radioembolization for the treatment of hepatic tumours: an institutional experience and review of the literature. Dig Dis Sci 55:2450-2458
6. Kennedy AS, Coldwell D, Nutting C et al (2006) Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Physiol 65:412-425
7. Coldwell D, Sangro B, Wasan H et al (2011) General selection criteria of patients for radioembolization of liver tumours: an international working group report. Am J Clin Oncol 34:337-341
8. Dezarn WA, Cessna JT, DeWerd LA et al (2011) Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90Y microsphere brachytherapy in the treatment of hepatic malignancies. Med Phys 38:4824-4845
9. Kennedy A, Nag S, Salem R et al (2007) Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 68:13-23
10. Lewandowski RJ, Sato KT, Atassi B et al (2007) Radioembolization with 90Y microspheres: angiographic and technical considerations. Cardiovasc Intervent Radiol 30:571-592
11. Salem R, Lewandowski RJ, Gates VL et al (2011) Research reporting standards for radioembolization of hepatic malignancies. J Vasc Interv Radiol 22:265-278
12. Louie JD, Kothary N, Kuo WT et al (2009) Incorporating cone-beam CT into the treatment planning for yttrium-90 radioembolization. J Vasc Interv Radiol 20:606-613
13. Meer AB, Louie JD, Abdelmaksoud MH et al (2011) Intrahepatic collateral supply to the previously embolized right gastric artery: a potential pitfall for nontarget radioembolization. J Vasc Interv Radiol 22:575-577
14. Abdelmaksoud MH, Hwang GL, Louie JD et al (2010) Development of new hepaticoenteric collateral pathways after hepatic arterial skeletonization in preparation for yttrium-90 radioembolization. J Vasc Interv Radiol 21:1385-1395
15. Northover JM, Terblanche J (1979) A new look at the arterial supply of the bile duct in man and its surgical implications. Br J Surg 66:379-384
16. Sjoquist KM, Goldstein D, Bester L (2010) A serious complication of selected internal radiation therapy: case report and literature review. Oncologist 15:830-835
17. South CD, Meyer MM, Meis G et al (2008) Yttrium-90 microsphere induced gastrointestinal tract ulceration. World J Surg Oncol 6:93
18. Thamboo TP, Wai CT, Lim LG, Wang SC (2008) Late gastric ulceration and cytomegalovirus infection following selective internal radiation therapy (SIRT) of the liver. Pathology 40:303-305
19. Parke WW, Michels NA, Ghosh GM (1963) Blood supply of the common bile duct. Surg Gynecol Obstet 117:47-55
20. Barentsz MW, Vente MA, Lam MG et al (2011) Technical solutions to ensure safe yttrium-90 radioembolization in patients with initial extrahepatic deposition of (99m)technetium-albumin macroaggregates. Cardiovasc Intervent Radiol 34:1074-1079
21. Hill S, Amesur NB, Zajko AB et al (2012) Reconsidering the necessity for prophylactic embolization of the gastroduodenal artery and right gastric artery prior to radioembolization of the liver with Yttrium-90 microspheres. J Vasc Intervent Radiol 23:S160
22. Bilbao JI, Garrastachu P, Herraiz MJ et al (2010) Safety and efficacy assessment of flow redistribution by occlusion of intrahepatic vessels prior to radioembolization in the treatment of liver tumours. Cardiovasc Intervent Radiol 33:523-531